When did Evommune report Q4 2025 earnings?

Evommune (EVMN) reported Q4 2025 earnings on March 5, 2026 before market open.

What were Evommune 's Q4 2025 revenue and EPS?

Evommune reported revenue of $1.5M and diluted EPS of $-1.43 for Q4 2025.

Did Evommune beat estimates in Q4 2025?

EPS missed the consensus estimate of $-0.82 by $0.61.

Where can I find Evommune 's Q4 2025 SEC filings?

You can read the 10-K periodic report (0001213900-26-035675) directly on SEC EDGAR. The filing index links above go to sec.gov.

Evommune EVMN Q4 2025 Annual earnings

Reported March 5, 2026 · Before market open

Revenue$1.5M Diluted EPS-$1.43Miss by $0.61

EPS estimate-$0.82

Next report

Aug 6, 2026 (in a month)

Revenue estimate$1.3M

EPS estimate-$0.68

Financials

Q4 2025

Income statement

See full

Revenue$1.5M-11.0%

Gross profit$670.8K-32.2%

Operating income-$1.1M-734%

Net income$852.3K+407%

EPS (diluted)$0.02+150%

Balance sheet

See full

Cash & equivalents$2.7M+1,217%

Total debt$2.1M-1.6%

Total equity$1.5M+1,400%

Total assets$9.1M+27.0%

Cash flow

See full

Operating cash flow-$2.7M-4,996%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation & ratios

Valuation

as of 12/31/25

See full

Market cap$539.69M—

Enterprise value$539.07M—

P/S81.6×—

Profitability

See full

Gross margin52.7%—

Operating margin-21.2%—

Returns & leverage

See full

Debt / equity1.4×—

Current ratio0.9×+0.4×

Versus estimates

Revenue

Q3 2025$10.0MBeat by $6.7M

Diluted EPS

Q1 2026-$0.64Beat by $0.19

Q4 2025-$1.43Miss by $0.61

Q3 2025-$8.07Miss by $1.99

Ask the moment Evommune reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Evommune report Q4 2025 earnings?: Evommune (EVMN) reported Q4 2025 earnings on March 5, 2026 before market open.
What were Evommune 's Q4 2025 revenue and EPS?: Evommune reported revenue of $1.5M and diluted EPS of $-1.43 for Q4 2025.
Did Evommune beat estimates in Q4 2025?: EPS missed the consensus estimate of $-0.82 by $0.61.
Where can I find Evommune 's Q4 2025 SEC filings?: You can read the 10-K periodic report (0001213900-26-035675) directly on SEC EDGAR. The filing index links above go to sec.gov.